EV/EBITDA
-1.16
-0.02-1.75%
5 min ago
Summary
- As of February 24, 2025, INZY EV/EBITDA is -1.16, with a fall of -0.02 (-1.75%) during the most recent trading day.
- Over the past year, INZY EV/EBITDA has increased by +4.26 (+78.60%).
- INZY EV/EBITDA is now -1188.89% below its all-time high of -0.09.
Performance
INZY EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
INZY EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | -1.8% | +1.9% | +2.4% |
1 m1 month | +7.2% | -7.4% | -9.2% |
3 m3 months | +48.4% | -48.5% | -54.5% |
6 m6 months | +76.5% | -73.5% | -76.3% |
ytdytd | +47.0% | -47.1% | -53.1% |
1 y1 year | +78.6% | -71.2% | -77.5% |
5 y5 years | - | - | - |
INZY EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -1.8% | -1.36 | +14.7% | |
3 m | 3-month | -1.14 | -1.8% | -2.56 | +54.7% |
6 m | 6-month | -1.14 | -1.8% | -5.49 | +78.9% |
1 y | 1-year | -1.14 | -1.8% | -7.15 | +83.8% |
3 y | 3-year | -0.09 | -1188.9% | -7.15 | +83.8% |
5 y | 5-year | -0.09 | -1188.9% | -23.02 | +95.0% |
alltime | all time | -0.09 | -1188.9% | -23.02 | +95.0% |
Inozyme Pharma EV/EBITDA History
Date | Value |
---|---|
2025 | -1.16(-47.0%) |
2024 | -2.19(-49.0%) |
2023 | -4.29(+1616.0%) |
Date | Value |
---|---|
2022 | -0.25(-90.1%) |
2021 | -2.53(-68.5%) |
2020 | -8.02 |
FAQ
- What is Inozyme Pharma EV/EBITDA?
- What is the all time high EV/EBITDA for Inozyme Pharma?
- What is INZY EV/EBITDA year-to-date change?
- What is Inozyme Pharma EV/EBITDA year-on-year change?
What is Inozyme Pharma EV/EBITDA?
The current EV/EBITDA of INZY is -1.16
What is the all time high EV/EBITDA for Inozyme Pharma?
Inozyme Pharma all-time high EV/EBITDA is -0.09
What is INZY EV/EBITDA year-to-date change?
Inozyme Pharma EV/EBITDA has changed by +1.03 (+47.03%) since the beginning of the year
What is Inozyme Pharma EV/EBITDA year-on-year change?
Over the past year, INZY EV/EBITDA has changed by +4.26 (+78.60%)